Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02580448
Title A Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of VT-464 in Patients With Advanced Breast Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Innocrin Pharmaceutical
Indications

triple-receptor negative breast cancer

estrogen-receptor positive breast cancer

Therapies

VT-464

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Wallace Tumor Institute- University of Alabama Birmingham Alabama 35249 United States Details
Clearview Cancer Institute Huntsville Alabama 35805 United States Details
University of Colorado Aurora Colorado 80045 United States Details
Rocky Mountain Cancer Centers Lakewood Colorado 80228 United States Details
Florida Cancer Specialists Fort Myers Florida 33916 United States Details
Florida Cancer Specialists- North Saint Petersburg Florida 33705 United States Details
Georgia Cancer Center at Augusta University Augusta Georgia 30912 United States Details
SCRI - HCA Midwest Division Kansas City Kansas 61432 United States Details
University of Louisville Hospital / James Brown Cancer Center Louisville Kentucky 40202 United States Details
Maryland Oncology Hematology Silver Spring Maryland 20902 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Masonic Cancer Center Minneapolis Minnesota 55455 United States Details
Cancer Network/Oncology Associates PC Omaha Nebraska 68118 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
North Shore Hematology Oncology Associates East Setauket New York 11733 United States Details
Memorial Sloan Kettering New York New York 10065 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Novant Health Presbyterian Medical Center - Oncology Research Charlotte North Carolina 28204 United States Details
Duke University Durham North Carolina 27710 United States Details
Gabrail Cancer Center Research Canton Ohio 44718 United States Details
Oncology Hematology Care, Inc Cincinnati Ohio 45242 United States Details
The Ohio State University Columbus Ohio 43202 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
OHSU Knight Cancer Institute Portland Oregon 97239 United States Details
Charleston Hematology and Oncology Associates Charleston South Carolina 29414 United States Details
Precision Cancer Research/Brig Center for Cancer Care and Survivorship, LLC Knoxville Tennessee 37909 United States Details
SCRI Tenessee Oncology Nashville Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Centers Dallas Texas 75230 United States Details
The University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
The Center for Cancer and Blood Disorders (Fort Worth) Fort Worth Texas 76104 United States Details
US Oncology Fort Worth Texas 76177 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field